What Researchers Did
Researchers conducted a systematic review to identify, evaluate, and summarize randomized controlled trials on treatments for sudden sensorineural hearing loss (SSHL).
What They Found
They identified 21 randomized controlled trials on various SSHL treatments, with validity scores ranging from 2 to 8 out of 9. Positive results were reported for systemic and intratympanic steroids, batroxobin, magnesium, vitamin E, and hyperbaric oxygen, though each had serious limitations. No significant audiometric outcome differences were found for antiviral or hemodilution agents.
What This Means for Canadian Patients
Canadian patients experiencing sudden sensorineural hearing loss may discuss potential treatments like steroids or hyperbaric oxygen with their healthcare providers, while acknowledging the current evidence has limitations. Further high-quality research is needed to establish definitive treatment guidelines for this condition.
Canadian Relevance
This systematic review was conducted by Canadian researchers, contributing to the global understanding of sudden sensorineural hearing loss treatments. The findings are relevant for Canadian clinicians and patients considering treatment options for SSHL.
Study Limitations
The review highlighted serious limitations in the included studies, such as inconsistent diagnostic criteria for SSHL and poorly described randomization methods in most trials.